| 发明名称 |
CRYSTAL FORMS |
| 摘要 |
The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern at values of two theta (°2θ) of 6.0, 6.7, 10.4, 11.9, 17.5, 17.7, 21.5, 22.0, 22.7, and 24.2. |
| 申请公布号 |
US2015175612(A1) |
申请公布日期 |
2015.06.25 |
| 申请号 |
US201414559101 |
申请日期 |
2014.12.03 |
| 申请人 |
AbbVie Inc. |
发明人 |
Brackemeyer Paul J.;Diwan Moiz;Gong Yuchuan;Pal Agnes E.;Sheikh Ahmad Y.;Wagaw Seble H.;Zhang Geoff G. |
| 分类号 |
C07D487/04 |
主分类号 |
C07D487/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A crystalline form of Compound I, wherein said crystalline form has characteristic peaks in PXRD pattern at values of two theta (°2θ) of 6.7, 7.0, 10.5, 12.0, 17.6, 20.2, 21.9, 22.0, 22.6, and 23.1. |
| 地址 |
North Chicago IL US |
